Copyright © 2016
Aridis Pharmaceuticals, Inc.
5941 Optical Court, San Jose, CA 95138
Human antibodies evolved in nature primarily to fight infections in the human host. We are exploring the human immune repertoire to identify naturally occurring antibodies to develop “Immunotherapies” to fight infections. We believe this offers a key solution to resolving the antibiotic drug resistance crisis and improve the treatment of serious life-
The human immune system has protected us for over 6 million years, well before any antibiotics were ever invented, and can be remarkably effective in fighting even the most deadly infections such as Ebola, Pandemic influenza. This is evidenced by the existence of rare subsets of infection survivors for all kinds of infectious diseases. Arguably the most important component of the immune system is the monoclonal antibodies (mAbs), which are molecules which designed to bind and neutralize the pathogens. A key solution to resolving the antibiotic drug resistance crisis is to explore the native capabilities of the human immune system to identify potent antibodies that can serve as safe, natural anti-
Aridis is mining the human immune response for rare, protective monoclonal antibodies from infection survivors or effectively immunized patients. Our diversified portfolio of anti-
The Human Monoclonal Antibody (Mab) Molecule.
Aridis Discovery and Clinical Strategy
Breakthrough Therapies for
Antibiotic Resistant Infections